Clinical trials
Terminated Phase 1 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 5 |
| 2022 | 4 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Fred Hutchinson Cancer Center | 3 |
| Gilead Sciences | 2 |
| National Cancer Institute (NCI) | 2 |
| Pfizer | 2 |
| AbbVie | 1 |
| Acrotech Biopharma Inc. | 1 |
| Antengene Discovery Limited | 1 |
| Antengene Therapeutics Limited | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 40 |
| Leukemia, Myeloid, Acute | 10 |
| Multiple Myeloma | 8 |
| Hodgkin Disease | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Myelodysplastic Syndromes | 6 |
| Recurrence | 6 |
| Lymphoma, Mantle-Cell | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Neoplasms | 5 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.